Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Iwona Dachowska"'
Autor:
Paweł Marschollek, Karolina Liszka, Monika Mielcarek-Siedziuk, Iwona Dachowska-Kałwak, Natalia Haze, Anna Panasiuk, Igor Olejnik, Tomasz Jarmoliński, Jowita Frączkiewicz, Zuzanna Gamrot, Anna Radajewska, Iwona Bil-Lula, Krzysztof Kałwak
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1622 (2024)
CD19-targeted CAR-T cell therapy has revolutionized the treatment of relapsed/refractory (r/r) pre-B acute lymphoblastic leukemia (ALL). However, it can be associated with acute toxicities related to immune activation, particularly cytokine release s
Externí odkaz:
https://doaj.org/article/034a291f37db42ef86144deadc9e8116
Autor:
Aleksandra Grzegorczyk, Zuzanna Marczyńska, Rafał Matkowski, Marcin Ziętek, Wojciech Pietras, Elżbieta Latos-Grażyńska, Krzysztof Kałwak, Iwona Dachowska-Kałwak
Publikováno v:
Central European Journal of Immunology, Vol 48, Iss 3, Pp 251-256 (2023)
This study presents a case of a 17-year-old female patient who had previously undergone surgical resection of melanoma in the right periscapular area. She was administered adjuvant treatment with the PD-1 inhibitor nivolumab as monotherapy. The mecha
Externí odkaz:
https://doaj.org/article/4595000100a34fafa64bfb052c55feb8
Autor:
Katarzyna Bobeff, Agata Pastorczak, Zuzanna Urbanska, Walentyna Balwierz, Edyta Juraszewska, Jacek Wachowiak, Katarzyna Derwich, Magdalena Samborska, Krzysztof Kalwak, Iwona Dachowska-Kalwak, Paweł Laguna, Iwona Malinowska, Katarzyna Smalisz, Jolanta Gozdzik, Aleksandra Oszer, Bartosz Urbanski, Maciej Zdunek, Tomasz Szczepanski, Wojciech Mlynarski, Szymon Janczar
Publikováno v:
Children, Vol 10, Iss 4, p 745 (2023)
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating signi
Externí odkaz:
https://doaj.org/article/98a8dfe4a61d4af7bc0b568d64fad2c4
Autor:
Paweł Marschollek, Karolina Liszka, Monika Mielcarek-Siedziuk, Blanka Rybka, Renata Ryczan-Krawczyk, Anna Panasiuk, Igor Olejnik, Jowita Frączkiewicz, Iwona Dachowska-Kałwak, Agnieszka Mizia-Malarz, Tomasz Szczepański, Wojciech Młynarski, Jan Styczyński, Katarzyna Drabko, Grażyna Karolczyk, Ewa Gorczyńska, Jan Maciej Zaucha, Krzysztof Kałwak
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2915 (2022)
The optimal bridging therapy before CAR-T cell infusion in pediatric relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r BCP-ALL) still remains an open question. The administration of blinatumomab prior to CAR-T therapy is contr
Externí odkaz:
https://doaj.org/article/59ce3a5d070e430689de72587b548172
Autor:
Arkadiusz Michalak, Szymon Gałczyński, Iwona Dachowska, Agnieszka Szadkowska, Andrzej Gawrecki, Dorota Zozulińska-Ziółkiewicz
Publikováno v:
Acta Diabetologica
Aims To analyze physical performance and diabetes-related outcomes in adolescents with type 1 diabetes (T1DM) during two semi-competitive football matches utilising precise physical activity monitoring. Methods The study was conducted during an annua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abd01d885631c902a6cba72fb08c8d22
https://doi.org/10.1007/s00592-019-01371-0
https://doi.org/10.1007/s00592-019-01371-0
Autor:
Joanna Trelińska, Sergiusz Jozwiak, Katarzyna Kotulska, Wojciech Fendler, Iwona Dachowska, Wojciech Młynarski, Dobromila Baranska
Publikováno v:
Pediatric Blood & Cancer. 62:616-621
Background The aim of the study was to investigate factors affecting response to everolimus, a mammalian-target-of-rapamycin (mTOR) inhibitor, of subependymal giant cell astrocytomas (SEGA) in patients with tuberous sclerosis complex (TSC). Methods T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa9b6b9872989c7e0984cf724ee27ae6
https://doi.org/10.1002/pbc.25368
https://doi.org/10.1002/pbc.25368
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wojciech Młynarski, Piotr Gnys, Karolina Antosik, Joanna Trelińska, Maciej Borowiec, Katarzyna Kotulska, Wojciech Fendler, Sergiusz Jozwiak, Iwona Dachowska
Publikováno v:
Orphanet Journal of Rare Diseases
Background Tuberous sclerosis (TSC) is a monogenic disease resulting from defects of the TSC1 or TSC2 genes, which encode the proteins forming hamartin-tuberin tumor suppressor complex, the mammalian target of rapamycin complex (mTOR). The mTOR pathw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817561a8496846540c89a5df70fb8688
https://doi.org/10.1186/s13023-016-0512-1
https://doi.org/10.1186/s13023-016-0512-1
Autor:
Joanna, Trelinska, Iwona, Dachowska, Dobromila, Baranska, Konrad, Stawiski, Katarzyna, Kotulska, Wojciech, Fendler, Sergiusz, Jozwiak, Wojciech, Mlynarski
Publikováno v:
Pediatric bloodcancer. 64(6)
One of the therapeutic options for patients with tuberous sclerosis (TCS) and subependymal giant cell astrocytoma (SEGA) is everolimus treatment once daily, every day, to attain trough concentrations of 5-15 ng/ml (standard treatment). The aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f02507927f427c53f1fd2c77a8409a60
https://pubmed.ncbi.nlm.nih.gov/27860334
https://pubmed.ncbi.nlm.nih.gov/27860334
Autor:
Sergiusz Jóźwiak, Wojciech Fendler, Wojciech Młynarski, Katarzyna Kotulska, Iwona Dachowska, Joanna Trelińska
Publikováno v:
Pharmacological reports : PR. 68(5)
Background The purpose of the study was to evaluate lipid homeostasis before and after treatment of everolimus, the mammalian target of the rapamycin (mTOR) inhibitor, among patients with tuberous sclerosis complex (TSC). Methods The study group cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac3a831d2a1e50fb36d71cde121d85b8
https://pubmed.ncbi.nlm.nih.gov/27423526
https://pubmed.ncbi.nlm.nih.gov/27423526